Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 301,034 | 154,584 | 5,421 | 1,253 | 9,757 |
| Cost of Goods | 34,193 | 7,353 | 101 | N/A | N/A |
| Gross Profit | 266,841 | 147,231 | 5,320 | 1,253 | 9,757 |
| Operating Expenses | 610,662 | 319,222 | 272,151 | 221,437 | 143,546 |
| Operating Income | -343,628 | -171,638 | -266,730 | -220,184 | -133,789 |
| Interest Expense | 0 | 0 | 535 | 0 | 0 |
| Other Income | -18,982 | 123,010 | 0 | 154 | -2,000 |
| Pre-tax Income | -362,610 | -48,628 | -267,265 | -220,030 | -135,789 |
| Income Tax | -692 | 2,060 | 0 | 0 | N/A |
| Net Income Continuous | -361,918 | -50,688 | -267,265 | -220,030 | -135,789 |
| Net Income | $-361,918 | $-50,688 | $-267,265 | $-220,030 | $-135,789 |
| EPS Basic Total Ops | -5.46 | -0.86 | -5.49 | -5.20 | -3.39 |
| EPS Basic Continuous Ops | -5.46 | -0.86 | -5.49 | -5.20 | -3.39 |
| EPS Diluted Total Ops | -5.46 | -0.86 | -5.49 | -5.20 | -3.39 |
| EPS Diluted Continuous Ops | -5.46 | -0.86 | -5.49 | -5.20 | -3.39 |
| EPS Diluted Before Non-Recurring Items | -5.46 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-339,055 | $-164,434 | $-261,039 | $-214,285 | $-127,667 |